Comparative Effectiveness of Ustekinumab Versus Vedolizumab in Treating Crohn's Disease After Failure of Anti-TNF Agents: Real-World Evidence

被引：0
|
作者：
Alamer, A. [1 ]
Al Lehaibi, L. [2 ]
Alomar, M. [2 ]
Aldhuwayan, F. [2 ]
Alshouish, S. [2 ]
Al-Ali, A. [3 ]
Almudhry, Z. [4 ]
Almulhim, A. [5 ]
Althagafi, A. [6 ]
Aldosari, S. [7 ]
Alameel, T. [8 ]
机构：
[1] Prince Sattam Bin Abdulaziz Univ, Dept Clin Pharm, Alkharj, Saudi Arabia
[2] Eastern Hlth Cluster Dammam Med Complex, Dept Clin Pharm, Dammam, Saudi Arabia
[3] Eastern Hlth Cluster Dhahran Eye Specialist Hosp, Dept Clin Pharm, Dhahran, Saudi Arabia
[4] Eastern Hlth Cluster Dammam Med Complex, Dept Med, Dammam, Saudi Arabia
[5] King Faisal Univ, Dept Pharm Practice, Coll Clin Pharm, Alhofuf, Saudi Arabia
[6] King Abdulaziz Univ, Dept Pharm Practice, Fac Pharm, Jeddah, Saudi Arabia
[7] Prince Sattam Bin Abdulaziz Univ, Dept Clin Pharm, Coll Pharm, Alkharj, Saudi Arabia
[8] King Fahad Specialist Hosp Dammam, Dept Med, Dammam, Saudi Arabia
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P688
引用
收藏
页码：I1297 / I1297
页数：1
相关论文
共 50 条
  • [31] Real-World Anti-TNF Dose Escalation in Patients With Crohn's Disease
    Rubin, David T.
    Kane, Sunanda
    Jaganathan, Srihari
    Palmer, Liisa
    Cyhaniuk, Anissa
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (05) : E135 - E140
  • [32] Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease
    Townsend, Tristan
    Razanskaite, Violeta
    Dodd, Susanna
    Storey, Daniel
    Michail, Stephanie
    Morgan, James
    Davies, Michael
    Penman, Douglas
    Watters, Christopher
    Swaminathan, Mira
    Sabine, Joseph
    Chapman, Adam
    Smith, Philip J.
    Flanagan, Paul K.
    Reilly, Ian
    Bodger, Keith
    Subramanian, Sreedhar
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1341 - 1352
  • [33] REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TNF IN BIOLOGIC-NAIVE CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY
    Mantzaris, Gerassimos J.
    Yarur, Andres J.
    Silverberg, Mark S.
    Zezos, Petros
    Stein, Dara
    Kim, Hankyul
    Lissoos, Trevor
    Lopez, Claudia
    Natsios, Athanasios
    Radulescu, Gabriela
    Patel, Haridarshan
    Demuth, Dirk
    Bressler, Brian
    GASTROENTEROLOGY, 2019, 156 (06) : S638 - S638
  • [34] THE REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN THE TREATMENT OF CROHN'S DISEASE
    Johnson, Amanda M.
    Barsky, Maria
    Ahmed, Waseem
    Zullow, Samantha
    Galati, Jonathan S.
    Jairath, Vipul
    Narula, Neeraj
    Peerani, Farhad
    Click, Benjamin H.
    Coburn, Elliot
    Dang, Thucnhi T.
    Gold, Stephanie
    Agrawal, Manasi
    Garg, Rajat
    Aggarwal, Manik
    Mohammad, Danah
    Halloran, Brendan P.
    Kochhar, Gursimran
    Todorowski, Hannah
    Mohy-Ud-Din, Nabeeha
    Izanec, James L.
    Teeple, Amanda M.
    Gasink, Christopher
    Muser, Erik
    Ding, Zhijie
    Swaminath, Arun
    Lakhani, Komal
    Hogan, Daniel
    Datta, Samit
    Ungaro, Ryan C.
    Singh, Siddharth
    Boland, Brigid
    Bohm, Matthew
    Fischer, Monika
    Sashi, Sagi
    Afzali, Anita
    Ullman, Thomas
    Lawlor, Garrett
    Baumgart, Daniel C.
    Chang, Shannon
    Hudesman, David
    Lukin, Dana J.
    Scherl, Ellen J.
    Colombel, Jean Frederic
    Sands, Bruce E.
    Siegel, Corey A.
    Regueiro, Miguel D.
    Sandborn, William J.
    Bruining, David H.
    Kane, Sunanda V.
    GASTROENTEROLOGY, 2021, 160 (06) : S121 - S121
  • [35] Real-World Experience of Ustekinumab in Crohn's Disease Patients With Prior Anti-TNF Therapy at a Tertiary Care Hospital
    Kartikeya, Tripathi
    Kevin, Groudan
    Jean, Chalhoub
    Arushika, Yedla
    Rohit, Singhania
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S17 - S17
  • [36] Efficacy of ustekinumab in patients with anti-TNF refractory Crohn's disease: data from a real-world study in Brazil
    Parra, R. S.
    Feitosa, M. R.
    Feres, O.
    Ribeiro da Rocha, J. J.
    Chebli, J. M. F.
    Chebli, L.
    Bertges, E. R.
    Gomes, T. N. F.
    Ambrogini, O., Jr.
    Alves Junior, A. J. T.
    Lubini, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S341 - S342
  • [37] Sequencing of Anti-TNF Agents and Vedolizumab in the Treatment of Crohn's Disease (CD)
    Huang, Zhongwen
    Ba, Yi
    Wang, Song
    Kamble, Pravin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S433 - S433
  • [38] Ustekinumab is associated with better effectiveness outcomes when compared with vedolizumab in Crohn's disease patients with prior anti-TNF failure: comparative effectiveness study from the ICC Registry
    Biemans, V.
    van der Woude, J.
    Dijkstra, G.
    van der Meulen-de Jong, A.
    Lowenberg, M.
    de Boer, N.
    Oldenburg, B.
    Srivastava, N.
    Jansen, J.
    Bodelier, A.
    West, R.
    de Vries, A.
    Haans, J.
    de Jong, D.
    Hoentjen, F.
    Pierik, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S114 - S116
  • [39] Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced Crohn's Disease patients
    Eroglu, Z.
    Yilmaz, V.
    Er, R. E.
    Soykan, I.
    Toruner, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1182 - I1182
  • [40] COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN'S DISEASE PATIENTS FAILURE TO TNF INHIBITORS
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mancuso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S140 - S141
12345